UniProt: Q96SZ5 (AEDO_HUMAN). Gene ADO (synonym C10orf22). Human, 270 aa, cytosolic.
EC 1.13.11.19. HGNC:23506. Chromosome 10.
ADO is a cytosolic non-heme mononuclear Fe(II) thiol dioxygenase of the cupin
superfamily. It is one of only two mammalian thiol dioxygenases (the other is
cysteine dioxygenase, CDO1), and is unusual in having two well-established
activities acting on chemically distinct substrate classes:
Cysteamine (2-aminoethanethiol) dioxygenase — oxidizes the sulfur of the
small molecule cysteamine to hypotaurine (a sulfinic acid), the second route of
hypotaurine/taurine biosynthesis complementing the CDO1/CSAD cysteinesulfinate
route. This was the founding assigned activity.
[file:human/ADO/ADO-uniprot.txt "Catalyzes the oxidation of cysteamine (2-aminoethanethiol) to hypotaurine"]
PMID:17581819
N-terminal cysteine dioxygenase of the Cys/N-degron (oxygen-sensing) pathway
— oxidizes the thiol of N-terminal cysteine residues of substrate proteins to
Cys-sulfinic acid, priming them for arginylation (by ATE1) and downstream
ubiquitin-mediated degradation. This makes ADO an enzymatic cellular O2 sensor.
Verified substrates: RGS4, RGS5, IL-32 (and, in reporter assays, the plant
ERF-VII RAP2.12 N-terminus).
PMID:31273118
PMID:31273118
Both activities use O2 as a co-substrate and incorporate both oxygen atoms
(true dioxygenase). ADO has a high KmO2 (>500 uM for peptide substrates),
significantly above the physiological range, which underpins its oxygen-sensing role.
PMID:31273118
PMID:31273118
GO currently has no dedicated molecular-function term for "oxygen-dependent
protein/peptidyl N-terminal cysteine dioxygenase activity" (the RHEA:70895 reaction:
N-terminal L-cysteinyl-[protein] + O2 = N-terminal S-hydroxy-S-oxy-L-cysteinyl-[protein]).
The nearest existing terms are GO:0047800 (cysteamine dioxygenase activity, the
small-molecule reaction), GO:0017172 (cysteine dioxygenase activity, the CDO1
reaction), and the BP term GO:0018171 (peptidyl-cysteine oxidation). This second
core catalytic activity of ADO is therefore proposed as a new MF term and, in the
interim, modeled through the process terms GO:0018171 (peptidyl-cysteine oxidation)
and GO:0031648 (protein destabilization) plus GO:0071456 (cellular response to hypoxia).
Rows on GO:0005739: IBA GO_REF:0000033 (was MARK_AS_OVER_ANNOTATED), IEA
GO_REF:0000107 Ensembl projection from mouse Q6PDY2 (was REMOVE), HTP PMID:34800366
(was MARK_AS_OVER_ANNOTATED). The earlier review called all three co-purification
and stated that UniProt places ADO in the cytosol. No sub-compartment rows.
Checked:
- UniProt Q96SZ5 has no SUBCELLULAR LOCATION comment at all, so no curated UniProt
location contradicts the mitochondrion; the cytosol call is Reactome TAS plus the
N-degron substrates.
- PAINT (interpro/panther/PTHR22966/PTHR22966-paint.tsv): PTN000539917 GO:0005739
IBD seeded by MGI:MGI:2685083 (mouse Ado).
- Mouse Q6PDY2 GO:0005739 (QuickGO): HDA PMID:18614015 (MitoCarta 2008, MGI) and IDA
PMID:37630723 (FlyBase). So the Ensembl projection is not circular.
- PMID:37630723 (full text): nuclear/cytoplasmic/mitochondrial fractionation of
primary inguinal adipocytes and DE 2.3 brown adipocytes PMID:37630723.
- PMID:34800366 (MitoCoP): built to exclude contaminants PMID:34800366. ADO itself is in the supplementary data only.
- Sequence: N-terminus MPRDNMASLIQRIARQACLTFRGS is Arg-rich, but UniProt annotates
no transit peptide and no TM; MobiDB-lite disorder at 21-48.
Outcome: root; all three rows changed to KEEP_AS_NON_CORE (dual cytosolic and
mitochondrial distribution; cytosol stays core). The REMOVE on the IEA row was a
consistency violation with the other rows and is no longer justified. No
sub-compartment row: the processed-looking lower band is a single line, with no TM
and no annotated presequence. Reference reviews for PMID:34800366, GO_REF:0000033
and GO_REF:0000107 updated; PMID:37630723 added; suggested experiment extended with
protease protection. This reverses an earlier call and should be double-checked.